A Bridging Study on Efficacy and Safety of [18F]Florbetaben PET for Diagnosis of Alzheimer Disease Subjects in Chinese Population
Clinical trial NCT05527288 · COMPLETED
Trial details
- NCT number
- NCT05527288
- Sponsor
- Sinotau Pharmaceutical Group
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-28
- Primary completion
- 2021-09-12
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.